Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure Chest

Previous Stories

Dr Boreham’s Crucible: Arovella Therapeutics

Jul 17 2023

Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics

Dr Boreham’s Crucible: PolyNovo

Jul 06 2023

Skin repair specialist PolyNovo remains confident in its firm growth path ahead

A New Dawn For Retail Food Group

Jun 29 2023

New research highlights Retail Food Group’s resilience to a consumer downturn and several capital-light growth opportunities

Johns Lyng And The Weather Factor

Jun 26 2023

Brokers explain a negative share price reaction to Johns Lyng’s upgraded FY23 guidance

Cloud And AI Trends Buoy Macquarie Technology

Jun 22 2023

Recent research on Macquarie Technology shows a strong near-term cloud demand outlook and a significant growth profile in coming years

Timing Seems Right For Alcidion Group

Jun 21 2023

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand

Capricorn Metals; New Gold Standard Rising

Jun 20 2023

New research on Capricorn Metals anticipates growth potential along with consistent profits and increasing dividends over time

Dr Boreham’s Crucible: Lumos Diagnostics

Jun 19 2023

Tim Boreham takes a look at Lumos Diagnostics, which specialises in rapid point-of-care tests to help healthcare professionals diagnose and manage medical conditions more accurately

Sigma’s Win Not Neccessarily Ebos’ Loss

Jun 14 2023

While Sigma Healthcare is a clear winner in gaining the Chemist Warehouse contract from Ebos, the damage is not that significant for Ebos in broker views

PeopleIN Stays The Course

Jun 08 2023

PeopleIN’s strategic review failed to realise extra value, nor was a sale forthcoming, but brokers back the company’s decision to stay the course

Analyse The Market From A Different Angle